Pharma Medical News about Cardiopulmonary bypass

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Rationale, design and baseline characteristics of the PRO-TECT II study: PROpofol CardioproTECTion for Type II diabetics: A randomized, controlled trial of high-dose propofol versus isoflurane preconditioning in patients undergoing on-pump coronary artery bypass graft surgery
Contemporary Clinical Trials , 05/20/09

Ansley DM et al. - The authors describe the rationale and methodology of the Pro-TECT II Study, a Phase II randomized controlled trial designed to explore the relationships of biomarkers of oxidative or nitrosative stress in diabetes, to determine the effect of propofol cardioprotection to counteract these effects in patients undergoing elective primary coronary bypass graft surgery with cardiopulmonary bypass, and to provide feasibility and sample size data needed to conduct Phase III trials.

<< Previous
Gastroprotective drugs in Australia: Utilization patterns between...

Next >>
SYNTAX Substudy Shows Positive Outcomes for Left Main Patients...

Which is better to preserve pulmonary function: Short-term or prolonged leukocyte depletion during cardiopulmonary bypass
The Journal of Thoracic and Cardiovascular Surgery, 10/19/09 Relevance Score: 68%

The eNOS 786C/T polymorphism in cardiac surgical patients with cardiopulmonary bypass is associated with renal dysfunction
European Journal of Cardio-Thoracic Surgery, 10/01/09 Relevance Score: 67%

Vardenafil protects against myocardial and endothelial injuries after cardiopulmonary bypass
European Journal of Cardio-Thoracic Surgery, 10/01/09 Relevance Score: 67%

Aortic Valve Replacement and Coronary Artery Bypass Grafting in a Rare Case of Congenital Hypofibrinogenemia
Annals of Thoracic Surgery, 10/13/09 Relevance Score: 66%

Magnesium supplementation during cardiopulmonary bypass to prevent junctional ectopic tachycardia after pediatric cardiac surgery: A randomized controlled study
The Journal of Thoracic and Cardiovascular Surgery, 10/13/09 Relevance Score: 66%